Novo Nordisk A/S NOVC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related del…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryDenmark
Employees59,337
TickerNOVC
Statistics
Market Cap$151.26B
Revenue (TTM)$207.23B
Net Income—
Net Margin—
EPS—
P/E22.93
P/S0.73
P/B1.83
EV/EBITDA1.73
ROE66.5%
Dividend Yield15.79%
Price$44.50
Data: Twelve Data · Revenue = mcap / P/S